Compare FFBC & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FFBC | STVN |
|---|---|---|
| Founded | 1863 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Major Banks | Containers/Packaging |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.7B |
| IPO Year | 2004 | 2021 |
| Metric | FFBC | STVN |
|---|---|---|
| Price | $34.46 | $19.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $30.71 | $25.67 |
| AVG Volume (30 Days) | ★ 1.1M | 334.9K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.34% | 0.39% |
| EPS Growth | ★ 10.83 | N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $27.67 | $9.67 |
| Revenue Next Year | $4.58 | $9.99 |
| P/E Ratio | $48.55 | ★ $27.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.09 | $12.89 |
| 52 Week High | $35.00 | $28.00 |
| Indicator | FFBC | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 65.08 | 64.16 |
| Support Level | $29.32 | $13.58 |
| Resistance Level | $35.00 | $22.00 |
| Average True Range (ATR) | 0.72 | 0.81 |
| MACD | 0.00 | 0.20 |
| Stochastic Oscillator | 82.85 | 84.35 |
First Financial Bancorp is a mid-sized, regional bank holding company. It engages in the business of commercial banking and other banking and banking-related activities through its subsidiary. The range of banking services provided to individuals and businesses includes commercial lending, real estate lending, and consumer financing. Real estate loans are loans secured by a mortgage lien on the real property of the borrower, which may either be residential property or commercial property. In addition, it offers deposit products that include interest-bearing and non-interest-bearing accounts, time deposits, and cash management services for commercial customers. A full range of trust and wealth management services is also provided through First Financial's Wealth Management line of business.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.